Shanghai University of Medicine and Health Sciences, Shanghai, China.
School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Virol J. 2021 Mar 8;18(1):51. doi: 10.1186/s12985-021-01518-y.
Human papillomavirus (HPV) infection is currently the main cause of cervical cancer and precancerous lesions in female patients. By analyzing 6-year patient data from Shanghai Zhoupu Hospital in China, we retrospectively analyzed the epidemiological characteristics of women to determine the relationship between HPV genotype and cytological test results.
From 2014 to 2019, 23,724 cases of cervical shedding were collected from Zhoupu Hospital in Shanghai, China. By comparing the results of HPV and ThinPrep cytology test (TCT), the HPV infection rate of patients was retrospectively analyzed. HPV genotyping using commercial kits can detect 21 HPV subtypes (15 high-risk and 6 low-risk). According to the definition of the Bethesda system, seven types of cervical cytology results were involved.
3816 among 23,724 women, nearly 16.08%, were infected with HPV. The top three highest HPV prevalence rates were high-risk type infection, including HPV52 (3.19%), 58 (2.47%) and 16 (2.34%). The number of single-type HPV infections (3480 (91.20%)) was much larger than the number of multi-type ones (336 (8.8%)). Single-type infections were mainly in women aged 50-60 (16.63%) and women under 30 (15.37%), while multi-type infections were more common in women over 60 (2.67%). By analyzing the long-term trends, between 2014 and 2019, HPV52, 58, and 16 subtypes changed significantly, and the HPV positive rate also changed significantly during this period. Among 4502 TCT positive women, 15 (4.04%), 125 (2.64%),159 (1.54%), 4202 (17.71%) and 1 (0.004%) had atypical glandular cells (AGC), high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL), atypical squamous cells (ASC)and cervical adenocarcinoma, respectively. The HPV infection rates were 66.08%, 63.99%, 115.20%, 119.50%, and 31.72% for NILM, AGCs, HSILs LSILs and ASCs, respectively.
HPV and TCT screening were very important steps in the secondary prevention of cervical cancer. Through the tracking and analysis of HPV and TCT results in this study, it can provide valuable information for Shanghai's HPV screening and prevention strategies, and provide references for clinical decision-making in the treatment of cervical cancer and precancerous lesions.
人乳头瘤病毒(HPV)感染是目前导致女性宫颈癌及癌前病变的主要原因。通过对中国上海周浦医院 6 年的患者数据进行分析,我们回顾性分析了女性的流行病学特征,以确定 HPV 基因型与细胞学检测结果之间的关系。
2014 年至 2019 年,从中国上海周浦医院收集了 23724 例宫颈脱落细胞。通过比较 HPV 和 ThinPrep 细胞学检测(TCT)的结果,回顾性分析了患者的 HPV 感染率。使用商业试剂盒进行 HPV 基因分型可检测 21 种 HPV 亚型(15 种高危型和 6 种低危型)。根据 Bethesda 系统的定义,涉及七种宫颈细胞学结果。
在 23724 名女性中,有 3816 名(近 16.08%)感染了 HPV。HPV 感染率最高的前三种高危型依次为 HPV52(3.19%)、58(2.47%)和 16(2.34%)。单一型 HPV 感染(3480 例(91.20%))的数量明显多于多型感染(336 例(8.8%))。单一型感染主要发生在 50-60 岁(16.63%)和 30 岁以下(15.37%)的女性,而多型感染则多见于 60 岁以上(2.67%)的女性。通过分析长期趋势,在 2014 年至 2019 年间,HPV52、58 和 16 型发生了显著变化,HPV 阳性率也在此期间发生了显著变化。在 4502 例 TCT 阳性的女性中,分别有 15 例(4.04%)、125 例(2.64%)、159 例(1.54%)、4202 例(17.71%)和 1 例(0.004%)患有非典型腺细胞(AGC)、高级别鳞状上皮内病变(HSIL)、低级别鳞状上皮内病变(LSIL)、非典型鳞状细胞(ASC)和宫颈腺癌。未发现上皮内瘤变或恶性肿瘤(NILM)、AGC、HSIL、LSIL 和 ASC 的 HPV 感染率分别为 66.08%、63.99%、115.20%、119.50%和 31.72%。
HPV 和 TCT 筛查是宫颈癌二级预防的重要步骤。通过对本研究中 HPV 和 TCT 结果的跟踪和分析,可以为上海的 HPV 筛查和预防策略提供有价值的信息,并为宫颈癌及癌前病变的临床治疗决策提供参考。